Scarica l'app Stockscreener
7.40
8.98%
0.61
Dopo l'orario di chiusura:
7.70
0.30
+4.05%
Kazia Therapeutics Limited Adr Borsa (KZIA) Ultime notizie
Zero voting power is reported as a holder amends its Kazia Therapeutics (KZIA) passive stake report. - Stock Titan
Kazia Therapeutics Switches ADR Depositary to JPMorgan as ADSs Remain on Nasdaq - The Globe and Mail
Kazia Therapeutics Switches ADR Depositary to JPMorgan as ADSs Remain on Nasdaq - The Globe and Mail
Kazia Therapeutics (NASDAQ: KZIA) shifts ADSs to JPMorgan - Stock Titan
Kazia Therapeutics Limited Announces Change of Sole Depositary for Its American Depositary Receipt - marketscreener.com
Immuron LimitedADR (IMRN) Peer Comparison – Compare with Others - Value Research
Paxalisib shrinks tumors in models as Kazia (NASDAQ: KZIA) lines up Phase 2 cancer trials - Stock Titan
BTIG raises Kazia Therapeutics stock price target on trial data By Investing.com - Investing.com Australia
BTIG raises Kazia Therapeutics stock price target on trial data By Investing.com - Investing.com India
BTIG raises Kazia Therapeutics stock price target on trial data By Investing.com - Investing.com UK
Kazia Therapeutics Expands Trial in HR+/HER2- Cancer | KZIA Stock News - Stock Titan
Kazia Therapeutics Limited Announces Oversubscribed Closing of Up to $120 Million Public Offering - PR Newswire
Kazia Therapeutics Limited Announces Oversubscribed Closing of Up to $120 Million Public Offering - The Manila Times
Kazia Therapeutics Limited Announces Oversubscribed Closing of Up to $120 Million Public Offering - The Globe and Mail
Kazia Therapeutics (NASDAQ: KZIA) unveils new investor site - Stock Titan
Kazia Therapeutics (KZIA) structures up to $120M around cancer drug trials - Stock Titan
Kazia Therapeutics LimitedADR Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Kazia Therapeutics stock falls on $40M public offering By Investing.com - Investing.com UK
Kazia Therapeutics prices $40 million public offering By Investing.com - Investing.com UK
Kazia Therapeutics Limited Announces Pricing of Up to $120 Million Public Offering - The Globe and Mail
Kazia Therapeutics Limited Announces Proposed Public Offering - The Manila Times
Kazia Therapeutics Limited Announces Pricing of Up to $120 Million Public Offering - PR Newswire
Kazia Therapeutics (KZIA) trims at-the-market offering program to $80M - Stock Titan
Kazia Therapeutics LimitedADR Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Kazia Therapeutics Limited Announces Proposed Public Offering - BioSpace
Kazia Therapeutics launches public offering of ADSs and warrants - Investing.com
Kazia Therapeutics Limited Announces Proposed Public Offering - The Globe and Mail
Jorey Chernett (NASDAQ: KZIA) reports multi-million ADS stake - Stock Titan
Ikarian Capital (KZIA) discloses 575,778 Kazia Therapeutics ADSs under 4.9% cap - Stock Titan
Kazia Therapeutics (KZIA) investor group reports 4.6% beneficial stake via ADS - Stock Titan
KZIA Q2 2026 Earnings: Wider-Than-Expected Loss Magnifies Cash Burn Concerns for Clinical-Stage Biotech - dars.gov.et
KZIA Q2 2026 Earnings: Wider-Than-Expected Loss Magnifies Cash Burn Concerns for Clinical-Stage BiotechAnalyst Coverage Count - dars.gov.et
KZIA Q2 2026 Earnings: Wider-Than-Expected Loss Magnifies Cash Burn Concerns for Clinical-Stage BiotechDividend Growth Analysis - https://www.dars.gov.et/
Kazia Therapeutics (KZIA) Holds Near $13.95 as Biotech ADR Consolidates Between Key LevelsParabolic SAR - vinanet.vn
Kazia files patent for breast cancer treatment strategy By Investing.com - Investing.com Nigeria
Kazia Therapeutics (NASDAQ: KZIA) files patent backed by TNBC data - Stock Titan
KZIA|Kazia Therapeutics Ltd|Price:12.802|Chg%:+0.542 - TradingKey
Kazia Therapeutics (KZIA) Slides 6% as Biotech Volatility Tests Key Support LevelCounter Trend Trade - dars.gov.et
Kazia (KZIA) Jumps +2.36% — Is Institutional Money Flowing In? 2026-07-17Gamma Squeeze - dars.gov.et
Kazia Therapeutics (KZIA) grants director 100,000 stock options - Stock Titan
KAZIA (NASDAQ: KZIA) CEO receives 150K RSUs and 500K stock options grant - Stock Titan
Kazia Therapeutics (KZIA) grants 150,000 stock options to VP Finance - Stock Titan
Kazia Therapeutics (KZIA) director awarded 100,000 ADS stock options - Stock Titan
Kazia Therapeutics (KZIA) grants 100,000 ADS options to CMC director - Stock Titan
Kazia Therapeutics (KZIA) director awarded 75,000 ADS stock options at $6.78 - Stock Titan
BTIG initiates Kazia Therapeutics stock with buy on cancer drug By Investing.com - Investing.com Nigeria
BTIG initiates Kazia Therapeutics stock with buy on cancer drug By Investing.com - Investing.com Canada
BTIG initiates Kazia Therapeutics stock with buy on cancer drug - Investing.com
Kazia Therapeutics Ltd Sponsored ADR Actuals & Estimates (NASDAQ:KZIA) - TradingView
Kazia Therapeutics (KZIA) awards 250,000 stock options to CSO - Stock Titan
1.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):